Osaic Holdings’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,350
| Closed | -$4.35K | – | 7505 |
|
|
2023
Q1 | $4.35K | Buy |
2,350
+1,100
| +88% | +$2.04K | ﹤0.01% | 6325 |
|
|
2022
Q4 | $1.28K | Buy |
1,250
+1,150
| +1,150% | +$1.18K | ﹤0.01% | 6742 |
|
|
2022
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 7507 |
|
|
2022
Q2 | $0 | Sell |
100
-32
| -24% | – | ﹤0.01% | 7536 |
|
|
2022
Q1 | $1K | Hold |
132
| – | – | ﹤0.01% | 6976 |
|
|
2021
Q4 | $1K | Buy |
132
+32
| +32% | +$242 | ﹤0.01% | 7139 |
|
|
2021
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 7050 |
|
|
2021
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 6872 |
|
|
2021
Q1 | $1K | Sell |
100
-9,799
| -99% | -$98K | ﹤0.01% | 6635 |
|
|
2020
Q4 | $69K | Buy |
9,899
+2,945
| +42% | +$20.5K | ﹤0.01% | 4316 |
|
|
2020
Q3 | $49K | Buy |
6,954
+96
| +1% | +$676 | ﹤0.01% | 4311 |
|
|
2020
Q2 | $47K | Buy |
6,858
+2,178
| +47% | +$14.9K | ﹤0.01% | 4230 |
|
|
2020
Q1 | $23K | Buy |
+4,680
| New | +$23K | ﹤0.01% | 4516 |
|